American Diabetes Association's 83rd Scientific Sessions recently concluded at the San Diego Conference Center in San Diego, California, USA, held On June, 2023. As one of the largest diabetes conferences globally, the conference drew over 12,000 esteemed physicians, scientists, and healthcare professionals from various parts of the world. In the medical information area, Gan & Lee's team prominently showcased the company's drug pipeline for the international market. The team also provided insights into the published clinical data that supports the company's Biologics License Application (BLA) at US FDA, thus laying a favorable and efficient groundwork for the subsequent launch of relevant products in the United States.

From June 19-21, 2023, CPHI China 2023 took place at the Shanghai New International Expo Center. Gan & Lee Pharmaceuticals showcased its comprehensive range of insulin preparations and devices at the event, effectively highlighting the company's remarkable accomplishments in R&D innovation, production technology, international commercialization, and other essential areas to industry peers, as well as domestic and international customers. CEO Du Kai personally attended the exhibition. Under the leadership of Mr. Du Kai, the international business affairs team held significant meetings with key customers, resulting in a mutually agreed cooperation intention for an insulin project. In the presence of government officials, both parties signed a memorandum of understanding on the spot, marking a momentous milestone.

In November 2022, the annual Pharmaceutical Ingredients World (CPHI Worldwide) was successfully held at Messe Frankfurt, Germany. As the world's largest professional exhibition for the pharmaceutical industry, CPHI Worldwide brings together world-class pharmaceutical giants and leading pharmaceutical companies from all over the world, attracting much attention from the industry. During the exhibition, Gan & Lee's international BD team received nearly 500 customers from all over the world and more than 70 meetings at the booth. This exhibition is an important step for the Gan & Lee brand towards the international stage of the pharmaceutical industry.

The 2022 World Diabetes Congress, organized by the International Diabetes Federation (IDF), was smoothly held in December at the Lisbon Convention Center in Portugal, providing a professional knowledge exchange forum for healthcare professionals, advocates and diabetes patients worldwide through a combination of online and offline formats. This time, Gan & Lee Pharmaceuticals appeared at the conference as an exhibitor, and as the only insulin company exhibiting offline at the conference, it drew wide attention from industry experts. In addition, Gan & Lee Pharmaceuticals conducted several rounds of academic exchanges and interactions with global experts in the field of diabetes, and the event was a complete success.

In September 2022, Gan & Lee Pharmaceuticals participated in the 58th Annual European Association for the Study of Diabetes (EASD) Conference in Stockholm, Sweden. The conference, organized by the European Association for the Study of Diabetes, attracts leading physicians, scientists and healthcare professionals from around the world through a combination of online and offline formats, providing the medical community with an opportunity to learn about diabetes cutting-edge technologies, groundbreaking research findings and a significant advances in the direction of treatment and care. For the first time, Gan & Lee Pharmaceuticals met with global experts in the field of diabetes in the form of an offline exhibition for academic exchange and discussion at the EASD Annual Meeting.

American Diabetes Association’s 82nd Scientific Sessions took place on June 3-7, 2022 at the Ernest N. Morial Convention Center (MCCNO) in New Orleans, Louisiana, USA. Gan & Lee Pharmaceuticals had a presence via their exhibit at the Conference. The event attracted more than 8,000 top doctors, scientists and healthcare professionals from all over the world through a combination of online and offline attendance, focusing on the latest, cutting-edge advances in diabetes research, prevention and care.As the only Chinese exhibitor, Gan & Lee has participated in the ADA tradeshow in the past. Presenting at conferences such as the ADA paves the way for the later commercializaiton of our diabetes products in the US and the European markets.

The 79th American Diabetes Association Scientific Annual Conference (ADA) was held in San Francisco, USA in 2019. As the only Chinese pharmaceutical enterprise in China invited to participate, Gan & Lee Pharmaceuticals set up a booth, and participated in 180 conferences, including seminars...

The 20th CPhI was held at the Shanghai New International Expo Center, where Gan & Lee Pharmaceuticals built a 121㎡ booth. Through videos, product and poster display, brochures, and the application of corporate logo and material combination, Gan & Lee shared the corporate culture...